OBSV News
Archived Headlines
- 7 US IPOs join next week's calendar; 2 deals launch Wednesday morning for week of 1/30 01/18/17
- Push, breathe: Reproductive health biotech ObsEva sets terms for $97 million IPO 01/17/17
- US IPO Week Ahead: Oilfield services company set to kick off 2017 01/13/17
- US IPO Week Ahead: Tech unicorn AppDynamics leads pack of potential IPO launches 01/06/17
- US IPO Weekly Recap: 2017 kicks off with a $1 billion IPO filing 01/06/17
See more
Biotechs stage comeback after slow quarter
The US IPO market snapped back in the 1Q17, but quarterly biotech activity fell to its lowest level since the 4Q12. Just three of the 25 deals came from biotechs in the 1Q17, compared to seven of the eight in the 1Q16. Recent IPO Tocagen (TOCA)...read more
US IPO Weekly Recap: AppDynamics taken out, 6 IPOs price
The star was taken, but the show must go on. Six companies went public this week, but AppDynamics (APPD) was notably missing as Cisco (Nasdaq: CSCO) acquired it for $3.7 billion the night before its scheduled pricing. Cisco paid a 68%...read more
ObsEva prices IPO at $15, within the range
ObsEva, a clinical-stage pharma developing therapies for women's reproductive health, raised $97 million by offering 6.5 million shares at $15, within the range of $14 to $16. ObsEva plans to list on the Nasdaq under the symbol OBSV. Credit Suisse, Jefferies...read more
US IPO Week Ahead: AppDynamics headlines rush of 8 IPOs
There are eight IPOs scheduled for the week ahead, which would tie the most active week of 2016. Software provider AppDynamics (APPD) leads the pack; as the ...read more